Association of cytomegalovirus (CMV)-specific CD4+ T lymphocyte reactivity and protective immunity against acquired immunodeficiency syndrome-related CMV retinitis.
Jacobson
Mark A
MA
Bredt
Barry M
BM
D017088:AIDS-Related Opportunistic Infections / Q000276:immunology*; D015703:Antigens, CD / Q000276:immunology; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology; D023241:Antiretroviral Therapy, Highly Active; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D003587:Cytomegalovirus / Q000276:immunology*; D017726:Cytomegalovirus Retinitis / Q000276:immunology*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007109:Immunity; D037181:Lectins, C-Type; D008213:Lymphocyte Activation / Q000276:immunology*; D012307:Risk Factors; D000099192:CD69 Antigens
D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D037181:Lectins, C-Type; D000099192:CD69 Antigens